THX Pharma Société Anonyme (EPA:ALTHX)
France · Delayed Price · Currency is EUR 3.200
-0.130 (-3.90%)
Oct 22, 2026, 5:35 PM CEST
EPA:ALTHX Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -2.03 | -3 | -1.77 | -6.83 | -6.57 | -8.15 |
Depreciation & Amortization | 0.12 | 0.11 | 0.1 | 0.26 | 0.33 | 1.16 |
Loss (Gain) From Sale of Assets | -0.14 | -0.11 | -0.02 | - | - | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.77 | - |
Loss (Gain) From Sale of Investments | 0 | - | - | - | - | - |
Other Operating Activities | 0.6 | 0.32 | -2.2 | -0.09 | -1.07 | 0.44 |
Change in Accounts Receivable | - | - | - | 0.32 | 1.07 | 0.54 |
Change in Other Net Operating Assets | 10.4 | 1.81 | 0.59 | -0.06 | 0.1 | -0.14 |
Operating Cash Flow | 8.94 | -0.88 | -3.3 | -6.4 | -5.37 | -6.14 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.26 | -0.26 | -0.03 | -0 | -0.04 | -0.02 |
Sale of Property, Plant & Equipment | 0.04 | 0.09 | 0.11 | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | -0.04 | -0.03 | -0.14 |
Investment in Securities | - | - | - | -0.02 | 0.4 | - |
Other Investing Activities | - | - | - | 0 | - | - |
Investing Cash Flow | -0.22 | -0.17 | 0.08 | -0.06 | 0.32 | -0.15 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 0.8 | 0.06 | - | 0.8 | 0.3 |
Long-Term Debt Repaid | - | -0.17 | -1.11 | -1.46 | -1.04 | -0.77 |
Net Debt Issued (Repaid) | -0.44 | 0.63 | -1.05 | -1.46 | -0.24 | -0.47 |
Issuance of Common Stock | 7.05 | 7.22 | 0.34 | 2.93 | 0.68 | 8.15 |
Other Financing Activities | - | - | - | 0.74 | 1.19 | -0.07 |
Financing Cash Flow | 6.61 | 7.85 | -0.71 | 2.22 | 1.63 | 7.61 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | - | - | - | 0.05 | - | - |
Net Cash Flow | 15.33 | 6.8 | -3.94 | -4.2 | -3.42 | 1.31 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 8.68 | -1.14 | -3.33 | -6.41 | -5.41 | -6.16 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 266.70% | -141.57% | -145.99% | -2162.21% | -1305.10% | -1023241.53% |
Free Cash Flow Per Share | 0.60 | -0.08 | -0.39 | -0.83 | -1.01 | -1.23 |
Levered Free Cash Flow | -4.08 | -2.94 | -1.02 | -4.32 | -2.54 | -4.59 |
Unlevered Free Cash Flow | -4.02 | -2.87 | -0.98 | -4.27 | -2.49 | -4.52 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | 10.4 | 1.81 | 0.59 | 0.26 | 1.16 | 0.4 |